FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN 5,025 EUROPEAN PATIENTS WITH AIDS

被引:25
作者
LUNDGREN, JD
BARTON, SE
LAZZARIN, A
DANNER, S
GOEBEL, FD
PEHRSON, P
MULCAHY, F
KOSMIDIS, J
PEDERSEN, C
PHILLIPS, AN
CLUMECK, N
DEWIT, S
SOMMEREIJNS, B
NIELSEN, JO
LUNDGREN, J
NIELSEN, T
JENSEN, G
SKINHOJ, P
BENTSEN, K
GERSTOFT, J
MELBYE, M
RANKI, A
VALLE, SL
KATLAMA, C
BERLUREAU, P
DIETRICH, M
SCHWANDER, S
PAPADOPOULOS, A
BANHEGYI, D
YUST, I
BENISHAI, Z
BENTWICH, Z
SACKS, T
MAAYAN, S
VELLA, S
CHIESI, A
ANCARANI, F
SCALISE, G
BERTAGGIA, A
FRANCAVILLA, E
CALONGHI, G
CARGNEL, A
ARLOTTI, M
CIAMMARUGHI, R
COLOMBA, A
DELALLA, F
FASSIO, P
FERLINI, A
FIACCADORI, F
PASETTI, G
机构
[1] ST STEPHENS CLIN, LONDON, ENGLAND
[2] UCL, SCH MED, LONDON W1N 8AA, ENGLAND
[3] UNIV MILAN, MILAN, ITALY
[4] ACAD MED CTR, AMSTERDAM, NETHERLANDS
[5] UNIV MUNICH, MED POLIKLIN, W-8000 MUNICH, GERMANY
[6] HUDDINGE SJUKHUS, HUDDINGE, SWEDEN
[7] ST JAMES HOSP, DUBLIN 8, IRELAND
[8] GEN HOSP ATHENS, ATHENS, GREECE
[9] ST PIERRE HOSP, BRUSSELS, BELGIUM
[10] FREDERIKSBERG UNIV HOSP, FREDERIKSBERG, DENMARK
[11] RIGSHOSP, DK-2100 COPENHAGEN, DENMARK
[12] HELSINKI UNIV, CENT HOSP, HELSINKI, FINLAND
[13] HOSP PITIE SALPETRIERE, PARIS, FRANCE
[14] BERNHARD NOCHT INST TROP MED, HAMBURG, GERMANY
[15] FIRST IKA HOSP, ATHENS, GREECE
[16] POSTGRAD MED UNIV, H-1389 BUDAPEST, HUNGARY
[17] ICHILOV HOSP, IL-64239 TEL AVIV, ISRAEL
[18] RAMBAM MED CTR, HAIFA, ISRAEL
[19] KAPLAN HOSP, IL-76100 REHOVOT, ISRAEL
[20] HADASSAH UNIV HOSP, IL-91120 JERUSALEM, ISRAEL
[21] IST SUPER SANITA, I-00161 ROME, ITALY
[22] UNIV ANCONA, ANCONA, ITALY
[23] OSPED CIVILE, PADUA, ITALY
[24] ARCISPEDALE SANTA MARIA NUOVA, REGGIONELL EMILIA, ITALY
[25] OSPITALE SACCO, MILAN, ITALY
[26] OSPITALE INFERMI RIMINI, RIMINI, ITALY
[27] OSPITALE CASA SOLE, PALERMO, ITALY
[28] OSPITALE CIVILE, VICENZA, ITALY
[29] OORR BERGAMO, BERGAMO, ITALY
[30] OSPITALE INFERMI FAENZA, FAENZA, ITALY
[31] OSPITALE RIUNITI, PARMA, ITALY
[32] OSPITALE NIGUARDA GRANDA, MILAN, ITALY
[33] OSPITALE AMEDEO SAVOIA, TURIN, ITALY
[34] OSPITALE L SACCO, MILAN, ITALY
[35] OSPITALE SANTA ANDREA, LA SPEZIA, ITALY
[36] PATOL MED UNIV CATANIA, CATANIA, ITALY
[37] UNIV CATTOLICA SACRO CUORE, ROME, ITALY
[38] UNIV SASSARI, I-07100 SASSARI, ITALY
[39] MONTELUCE POLICLIN, PERUGIA, ITALY
[40] OSPITALE GALLIERA, GENOA, ITALY
[41] OSPITALE SANTA MARIA CROCI, RAVENNA, ITALY
[42] OSPITALE MAGGIORE, NOVARA, ITALY
[43] OSPITALE SANTA MARIA MADDALENA, TRIESTE, ITALY
[44] OSPITALE SANTA MARIA MADDALENA, TURIN, ITALY
[45] CTR HOSP, LUXEMBOURG, LUXEMBOURG
[46] UNIV AMSTERDAM, ACAD ZIEKENHUIS, AMSTERDAM, NETHERLANDS
[47] HOSP SANTA MARIA, LISBON, PORTUGAL
[48] HOSP CURRY CABRAL, LISBON, PORTUGAL
[49] INST CARLOS III, MADRID, SPAIN
[50] HOSP GERMANS TRIAS & PUJOL, BARCELONA, SPAIN
关键词
D O I
10.1093/clinids/21.1.106
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study examined the factors associated with the development of a first episode of Pneumacystis carinii pneumonia (PCP) in 5,025 patients with AIDS, including 1,976 patients with primary PCP at the time of AIDS diagnosis and 635 with primary PCP occurring subsequently. Compared with untreated patients, patients treated with zidovudine were at similar risk of developing PCP during the first year of therapy but were at greater risk after longer intervals of treatment. The following factors were associated with an increased risk of PCP (either at the time of AIDS diagnosis or thereafter): lack of primary PCP prophylaxis, male homosexuality/bisexuality, diagnosis of AIDS in northern Europe, and CD4 cell count below 200 x 10(6)/L at the time of AIDS diagnosis. Patients with severe weight loss had a 60% higher risk of developing PCP during follow-up than those without such weight loss. Thus, the occurrence of PCP depended on geographic location, mode of acquisition of human immunodeficiency virus and AIDS, degree of immunodeficiency, and use of various treatment regimens.
引用
收藏
页码:106 / 113
页数:8
相关论文
共 27 条
[1]  
BARTON EG, 1969, AM J PATHOL, V54, P209
[2]   TRANSMISSION OF PNEUMOCYSTIS-CARINII FROM AIDS PATIENTS TO OTHER IMMUNOSUPPRESSED PATIENTS - A CLUSTER OF PNEUMOCYSTIS-CARINII PNEUMONIA IN RENAL-TRANSPLANT RECIPIENTS [J].
CHAVE, JP ;
DAVID, S ;
WAUTERS, JP ;
VANMELLE, G ;
FRANCIOLI, P .
AIDS, 1991, 5 (08) :927-932
[3]   PNEUMOCYSTIS-CARINII IS NOT UNIVERSALLY TRANSMISSIBLE BETWEEN MAMMALIAN-SPECIES [J].
GIGLIOTTI, F ;
HARMSEN, AG ;
HAIDARIS, CG ;
HAIDARIS, PJ .
INFECTION AND IMMUNITY, 1993, 61 (07) :2886-2890
[4]   ANALYSES OF RAT PNEUMOCYSTIS-CARINII ANTIGENS RECOGNIZED BY HUMAN AND RAT ANTIBODIES BY USING WESTERN IMMUNOBLOTTING [J].
GRAVES, DC ;
MCNABB, SJN ;
WORLEY, MA ;
DOWNS, TD ;
IVEY, MH .
INFECTION AND IMMUNITY, 1986, 54 (01) :96-103
[5]  
HAGLER DN, 1988, CLIN EXP IMMUNOL, V74, P7
[6]   TREATMENT FOR CEREBRAL TOXOPLASMOSIS PROTECTS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS [J].
HEALD, A ;
FLEPP, M ;
CHAVE, JP ;
MALINVERNI, R ;
RUTTIMANN, S ;
GABRIEL, V ;
RENOLD, C ;
SUGAR, A ;
HIRSCHEL, B .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :760-763
[7]   A CONTROLLED-STUDY OF INHALED PENTAMIDINE FOR PRIMARY PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA [J].
HIRSCHEL, B ;
LAZZARIN, A ;
CHOPARD, P ;
OPRAVIL, M ;
FURRER, HJ ;
RUTTIMANN, S ;
VERNAZZA, P ;
CHAVE, JP ;
ANCARANI, F ;
GABRIEL, V ;
HEALD, A ;
KING, R ;
MALINVERNI, R ;
MARTIN, JL ;
MERMILLOD, B ;
NICOD, L ;
SIMONI, L ;
VIVIRITO, MC ;
ZERBONI, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1079-1083
[9]   PROTEIN-CALORIE MALNUTRITION - HOST DETERMINANT FOR PNEUMOCYSTIS-CARINII INFECTION [J].
HUGHES, WT ;
PRICE, RA ;
SISKO, F ;
HAVRON, WS ;
KAFATOS, AG ;
SCHONLAND, M ;
SMYTHE, PM .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1974, 128 (01) :44-52
[10]   MONOCLONAL-ANTIBODIES TO PNEUMOCYSTIS-CARINII - IDENTIFICATION OF SPECIFIC ANTIGENS AND CHARACTERIZATION OF ANTIGENIC DIFFERENCES BETWEEN RAT AND HUMAN ISOLATES [J].
KOVACS, JA ;
HALPERN, JL ;
LUNDGREN, B ;
SWAN, JC ;
PARRILLO, JE ;
MASUR, H .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (01) :60-70